CVR 30724429Public limited company (A/S)Sundhedsvæsen i øvrigt i.a.n. (869090)HerlevFounded 17 Jul 2007
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about NORDIC BIOSCIENCE LABORATORY A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
9
CVR, 2015
Result
+24K
DKK, annual report 2018
Equity
2.2M
DKK, annual report 2018
NORDIC BIOSCIENCE HOLDING A/SCVR 30511271, 100% of capital and votes, until 4 May 2020
Thomas Nielsenuntil 31 Jan 2017
No current owner is registered.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 30511271100% of capital and votes26 Mar 2013 to 4 May 2020
CVR lists no current officers for this company.
17 Jul 2007 to 12 Nov 2026.
Dec 2015, monthly: 11 employees, 10 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 8 | 3 | 2 | No count | No count | No count | No count | 9 | 11 | 14 | 13 | 11 | 12 | 12 | 12 | 12 | 11 | 10 | 10 | 10 | 10 | 9 | 11 |
| FTE | 3 | 5 | 2 | 3 | 3 | 4 | 4 | 7 | 10 | 14 | 12 | 10 | 11 | 11 | 11 | 11 | 10 | 8 | 9 | 9 | 8 | 8 | 10 |
| Series | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Annual 2007 to 2009 and 2011 to 2014; quarterly Q1 2010 to Q4 2010; monthly Jan 2015 to Dec 2015.
Latest Dec 2015, published 24 Feb 2016. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|
| Gross profit | 16,137 | 17,604 | 939 | -100 | Not reported |
| Operating profit | Not reported | Not reported | +279 | -131 | +32 |
| Result for the year | +7,372 | +11,909 | +1,393 | -103 | +24 |
| Equity | 12,492 | 24,400 | 2,293 | 2,190 | 2,214 |
| Total assets | 26,274 | 30,035 | 13,873 | 13,596 | 2,251 |
| Employees (average) | Not reported | Not reported | Not reported | Not reported | 0 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | 249.4% | 9.1% | -94.4% | -110.6% | Not reportednote 1 |
| EBITDA | Not reportednote 2 | Not reportednote 2 | 475note 3 | -31note 3 | Not reportednote 4 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 114note 5 | 84note 5 | 0note 6 | Not reportednote 7 | Not reportednote 7 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Annual report 2018
1 Jan 2018 to 31 Dec 2018, published 8 Jun 2019
Annual report 2017
1 Jan 2017 to 31 Dec 2017, published 12 Apr 2018
Annual report 2016
1 Jan 2016 to 31 Dec 2016, published 31 May 2017
Annual report 2015
1 Jan 2015 to 31 Dec 2015, published 3 Jun 2016
Annual report 2014
1 Jan 2014 to 31 Dec 2014, published 8 Jun 2015
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For NORDIC BIOSCIENCE LABORATORY A/S, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 12 Nov 2026. Text such as the signing rule and purpose is shown as registered.
13 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Likvidation sluttet, og virksomheden opløst
Likvidatorer:
Fratrådte:
Thomas Nielsen, den 04.05.2020.
Revision:
Fratrådte:
DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 04.05.2020.
Ny adresse: Herlev Hovedgade 205, 2730 Herlev
Likvidation vedtaget 31.01.2017
Likvidatorer:
Tiltrådte:
Thomas Nielsen, den 31.01.2017.
Bestyrelse:
Fratrådte:
Bente Juel Christiansen, den 31.01.2017, Claus Henrik Christiansen, den 31.01.2017, Morten Asser Karsdal, den 31.01.2017.
Direktion:
Fratrådte:
Thomas Nielsen, den 31.01.2017.
Virksomheden tegnes af en likvidator.
Revision:
Fratrådte:
BAKER TILLY DENMARK GODKENDT REVISIONSPARTNERSELSKAB, den 31.01.2017.
Tiltrådte:
CVR-NR. 33963556 DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB, Weidekampsgade 6, 2300 København S, den 31.01.2017.
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Ny adresse: Herlev Hovedgade 205-207, 2730 Herlev
Ny kommune: Herlev
Ny adresse:
Glerupvej 2, 2610 Rødovre.
Ny kommune:
Rødovre.
Vedtægter ændret:
01.06.2013.
Nyt navn:
NORDIC BIOSCIENCE LABORATORY A/S.
Bestyrelse:
Udtrådt af bestyrelsen:
Aaron Christopher Timm, den 01.06.2013, Thomas Nielsen, den 01.06.2013, Ralph J. Reyes, den 01.06.2013.
Indtrådt i bestyrelsen:
Direktør, Dr. med Claus Henrik Christiansen, den 01.06.2013, Direktør Bente Juel Christiansen, den 01.06.2013, Morten Asser Karsdal, den 01.06.2013.
Direktion:
Udtrådt af direktionen:
Søren Hyllekvist, den 01.06.2013.
Indtrådt i direktionen:
Direktør Thomas Nielsen, den 01.06.2013.
Vedtægter ændret:
19.05.2010.
Nyt navn:
SYNARC RESEARCH LABORATORY A/S.
Vedtægter ændret:
26.10.2009.
Ny adresse:
Ballerup Byvej 222, 2750 Ballerup.
Ny kommune:
Ballerup.
Direktion:
Udtrådt af direktionen:
Thomas Nielsen, den 26.10.2009.
Indtrådt i direktionen:
Søren Hyllekvist, den 26.10.2009.
Revision:
Udtrådt af revisionen:
Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer, den 23.02.2009.
Indtrådt i revisionen:
CVR-NR. 24213714 DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB, Weidekampsgade 6, 2300 København S, den 23.02.2009.
Bestyrelse:
Udtrådt af bestyrelsen:
Claus Henrik Christiansen, den 01.11.2008, Bente Juel Christiansen, den 01.11.2008.
Indtrådt i bestyrelsen:
Aaron Christopher Timm (formand), den 01.11.2008, Ralph J. Reyes, den 01.11.2008.
Direktion:
Udtrådt af direktionen:
Per Qvist, den 01.11.2008.
Indtrådt i direktionen:
Thomas Nielsen, den 01.11.2008.
Selskabet er stiftet ved spaltning, den 17.07.2007 Selskabets aktiver og gæld er overdraget fra CVR-NR. 16584037 IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
Seneste vedtægtsdato:
17.07.2007.
Kapital:
kr. 500.000,00.
Indbetalingsmåde:
spaltning kr. 500.000,00 til kurs 8.831,00.
Bestyrelse:
Direktør, Dr. med Claus Henrik Christiansen, (formand), 6900 Lugano, Brc, Schweiz, den 17.07.2007, Direktør Bente Juel Christiansen, 6900 Lugano, Brc, Schweiz, den 17.07.2007, Direktør Thomas Nielsen, 2791 Dragør, den 17.07.2007.
Direktion:
Per Qvist, 2930 Klampenborg, den 17.07.2007.
Selskabet tegnes af to medlemmer af bestyrelsen i forening, af et medlem af bestyrelsen og en direktør i forening eller af den samlede bestyrelse.
Revision:
Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer, Strandboulevarden 89, 3., 2100 København Ø, den 17.07.2007.
Første regnskabsår:
01.01.2007 - 31.12.2007.
Regnskabsår:
01.01 - 31.12.
2 registered in CVR.
P-number 1015875387Herlev Hovedgade 205, 2730 Herlev
P-number 1013476396Glerupvej 2, 2610 Rødovre
